We serve Chemical Name:5-Amino-1-(3-chloro-4-fluorophenyl)-1H-pyrazole-4-carbonitrile CAS:175135-53-2 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:5-Amino-1-(3-chloro-4-fluorophenyl)-1H-pyrazole-4-carbonitrile
CAS.NO:175135-53-2
Synonyms:5-amino-1-(3-chloro-4-fluorophenyl)pyrazole-4-carbonitrile
Molecular Formula:C10H6ClFN4
Molecular Weight:236.63300
HS Code:2933199090
Physical and Chemical Properties:
Melting point:153-154ºC
Boiling point:301.2ºC at 760 mmHg
Density:1.453g/cm3
Index of Refraction:1.574
PSA:67.63000
Exact Mass:236.02700
LogP:2.69988
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:NONH for all modes of transpor
Packing Group:
Contact us for information like 5-amino-1-(3-chloro-4-fluorophenyl)pyrazole-4-carbonitrile chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,5-amino-1-(3-chloro-4-fluorophenyl)pyrazole-4-carbonitrile physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,5-amino-1-(3-chloro-4-fluorophenyl)pyrazole-4-carbonitrile Use and application,5-amino-1-(3-chloro-4-fluorophenyl)pyrazole-4-carbonitrile technical grade,usp/ep/jp grade.
Related News: After the IPO, he now owns a 53% stake, worth $3.1 billion, plus roughly $100 million in cash and other investments, including a winery in northeastern Italy. His sons Franco and Marco (the company’s vice chairman) each own 12% stakes worth about $730 million apiece. N4-benzoyl-1-[2-O-(2,3-di-O-acetyl-β-D-erythrofuranosyl)-5-O-(dimethoxytrityl)-β-D-ribofuranosyl]cytosine manufacturers Charles River Laboratories and AstraZeneca have maintained a strategic partnership since 2012, providing AstraZeneca with outsourced regulated safety and development support on a range of treatments and vaccines, including testing and facilitating the deployment of the vaccines Vaxzevria for COVID-19 and Fluenz for seasonal infleunza. phenyl (Z)-N-([1,1′-biphenyl]-2-ylsulfonyl)-N’-(4,6-dimethoxy-1,3,5-triazin-2-yl)carbamimidothioate suppliers After the IPO, he now owns a 53% stake, worth $3.1 billion, plus roughly $100 million in cash and other investments, including a winery in northeastern Italy. His sons Franco and Marco (the company’s vice chairman) each own 12% stakes worth about $730 million apiece. N-(5-methoxy-2-(phenylethynyl)phenethyl)-2-methylpropan-2-amine hydrochloride vendor & factory McNamara joined GSK from Novartis in 2015 when the two companies combined their OTC portfolios into a joint venture managed by GSK. He became head of GSK consumer health in 2016, taking the baton from Walmsley as she moved up the command chain to CEO of the entire group. Novartis in 2018 backed out of the collab, and after taking full control of the venture, GSK formed a new JV with Pfizer in 2019.,Grégoire holds a Masters’ degree in Fundamental Physics from Pierre and Marie Curie University.
